FDA Warning Letter — NovaRx
The FDA took a Warning Letter action against NovaRx on Jun 8, 2026 (New York, NY). The action was issued by CDER and concerns drugs products.
Action details
- Facility
- NovaRx
- Date
- Jun 8, 2026
- Fiscal Year
- 2026
- Product Type
- Drugs
- Center
- CDER
- Location
- New York, NY (United States)